Chongqing Zhifei Biological Products Co.,Ltd.’s Net Profit Dropped 33.3% in First Three Quarters of 2022
Listen to the full version

Chongqing Zhifei Biological Products Co.,Ltd. (重庆智飞生物制品股份有限公司) (300122.SZ) reported a net profit of 5.6 billion yuan in the first three quarters of 2022, down 33.3% year-on-year.
Meanwhile, the company posted 27.8 billion yuan in revenue, up 27.5% year-on-year.
At the end of the reporting period, it had 36.2 billion yuan in total assets and 13.9 billion yuan in total liabilities, with a liability-to-asset ratio of 38.4%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR